CompanyXTLBNasdaqNew York, NY

Xtl Biopharmaceuticals Ltd

SEC EDGAR ClinicalTrials.gov xtlbio.com

6-KAug 5Latest SEC filing, period to Aug 5

Jun 30Latest story

June 2026

XTL Biopharmaceuticals completes acquisition of Psyga Bio, pivots to psychedelic medicine

Jun 30M&AXtl Biopharmaceuticals Ltd